{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:23:44Z","timestamp":1792801424236,"version":"4.5.0"},"reference-count":85,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Endocrinology & Metabolism"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.tem.2021.11.005","type":"journal-article","created":{"date-parts":[[2021,12,21]],"date-time":"2021-12-21T00:11:35Z","timestamp":1640045495000},"page":"147-157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Digesting recent findings: gut alpha-synuclein, microbiome changes in Parkinson\u2019s disease"],"prefix":"10.1016","volume":"33","author":[{"given":"Ehraz","family":"Anis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aoji","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Brundin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrik","family":"Brundin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tem.2021.11.005_bb0005","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson's disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.tem.2021.11.005_bb0010","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/j.1365-2990.2007.00874.x","article-title":"Parkinson's disease: a dual-hit hypothesis","volume":"33","author":"Hawkes","year":"2007","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.tem.2021.11.005_bb0015","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1749-6632.2009.04365.x","article-title":"Parkinson's disease: the dual hit theory revisited","volume":"1170","author":"Hawkes","year":"2009","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.tem.2021.11.005_bb0020","doi-asserted-by":"crossref","first-page":"30","DOI":"10.5056\/jnm17105","article-title":"Gut microbiota dysfunction as reliable non-invasive early diagnostic biomarkers in the pathophysiology of Parkinson's disease: a critical review","volume":"24","author":"Nair","year":"2018","journal-title":"J. Neurogastroenterol. Motil."},{"key":"10.1016\/j.tem.2021.11.005_bb0025","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1212\/WNL.0b013e3181c34af5","article-title":"Medical records documentation of constipation preceding Parkinson disease: a case-control study","volume":"73","author":"Savica","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.tem.2021.11.005_bb0030","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/WCO.0000000000000112","article-title":"Premotor and nonmotor features of Parkinson's disease","volume":"27","author":"Goldman","year":"2014","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.tem.2021.11.005_bb0035","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/BF00687767","article-title":"Parkinson's disease: the presence of Lewy bodies in Auerbach's and Meissner's plexuses","volume":"76","author":"Wakabayashi","year":"1988","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.tem.2021.11.005_bb0040","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/nan.12486","article-title":"Detection of alpha-synuclein conformational variants from gastro-intestinal biopsy tissue as a potential biomarker for Parkinson's disease","volume":"44","author":"Ruffmann","year":"2018","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.tem.2021.11.005_bb0045","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.parkreldis.2017.09.001","article-title":"Fundamental limit of alpha-synuclein pathology in gastrointestinal biopsy as a pathologic biomarker of Parkinson's disease: comparison with surgical specimens","volume":"44","author":"Shin","year":"2017","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.tem.2021.11.005_bb0050","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1212\/WNL.0000000000001240","article-title":"Colonic mucosal a-synuclein lacks specificity as a biomarker for Parkinson disease","volume":"84","author":"Visanji","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.tem.2021.11.005_bb0055","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.neulet.2017.01.050","article-title":"Biochemical analysis of \u03b1-synuclein extracted from control and Parkinson's disease colonic biopsies","volume":"641","author":"Corbill\u00e9","year":"2017","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.tem.2021.11.005_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2019.134297","article-title":"Alteration of the fecal microbiota in North-Eastern Han Chinese population with sporadic Parkinson's disease","volume":"707","author":"Li","year":"2019","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.tem.2021.11.005_bb0065","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/mds.26069","article-title":"Gut microbiota are related to Parkinson's disease and clinical phenotype","volume":"30","author":"Scheperjans","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.tem.2021.11.005_bb0070","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.parkreldis.2016.08.019","article-title":"Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls","volume":"32","author":"Unger","year":"2016","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.tem.2021.11.005_bb0075","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.ebiom.2019.05.064","article-title":"Gut microbiota in Parkinson's disease: temporal stability and relations to disease progression","volume":"44","author":"Aho","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.tem.2021.11.005_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0142164","article-title":"Intestinal dysbiosis and lowered serum lipopolysaccharide-binding protein in Parkinson\u2019s disease","volume":"10","author":"Hasegawa","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.tem.2021.11.005_bb0085","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1111\/ene.14644","article-title":"Gut microbiota and metabolome distinctive features in Parkinson disease: focus on levodopa and levodopa-carbidopa intrajejunal gel","volume":"28","author":"Melis","year":"2021","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.tem.2021.11.005_bb0090","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.bbr.2019.02.039","article-title":"Diagnostic utility of gut \u03b1-synuclein in Parkinson's disease: a systematic review and meta-analysis","volume":"364","author":"Bu","year":"2019","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.tem.2021.11.005_bb0095","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000011337","article-title":"Gastrointestinal nervous system \u03b1-synuclein as a potential biomarker of Parkinson disease","volume":"97","author":"Yan","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.tem.2021.11.005_bb0100","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1002\/mds.28553","article-title":"Increased accumulation of \u03b1-synuclein in inflamed appendices of Parkinson's disease patients","volume":"36","author":"Chen","year":"2021","journal-title":"Mov. Disord."},{"key":"10.1016\/j.tem.2021.11.005_bb0105","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s40035-018-0118-8","article-title":"Age-dependent alpha-synuclein accumulation and aggregation in the colon of a transgenic mouse model of Parkinson's disease","volume":"7","author":"Chen","year":"2018","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.tem.2021.11.005_bb0110","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aar5280","article-title":"The vermiform appendix impacts the risk of developing Parkinson's disease","volume":"10","author":"Killinger","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.tem.2021.11.005_bb0115","doi-asserted-by":"crossref","first-page":"510","DOI":"10.3389\/fneur.2020.00510","article-title":"Appendectomy, tonsillectomy and Parkinson's disease risk: a Swedish register-based study","volume":"11","author":"Liu","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.tem.2021.11.005_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/CS20180956","article-title":"The vermiform appendix: an immunological organ sustaining a microbiome inoculum","volume":"133","author":"Vitetta","year":"2019","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.tem.2021.11.005_bb0125","doi-asserted-by":"crossref","first-page":"5134","DOI":"10.1038\/s41467-021-25474-x","article-title":"Epigenetic inactivation of the autophagy-lysosomal system in appendix in Parkinson's disease","volume":"12","author":"Gordevicius","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tem.2021.11.005_bb0130","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/BF00294234","article-title":"Parkinson's disease: an immunohistochemical study of Lewy body-containing neurons in the enteric nervous system","volume":"79","author":"Wakabayashi","year":"1990","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.tem.2021.11.005_bb0135","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.neulet.2005.11.012","article-title":"Gastric alpha-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology","volume":"396","author":"Braak","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.tem.2021.11.005_bb0140","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s00401-010-0664-3","article-title":"Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders","volume":"119","author":"Beach","year":"2010","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.tem.2021.11.005_bb0145","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s10072-016-2745-0","article-title":"\u03b1-synuclein in the colon and premotor markers of Parkinson disease in neurologically normal subjects","volume":"38","author":"Kim","year":"2017","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.tem.2021.11.005_bb0150","doi-asserted-by":"crossref","first-page":"S313","DOI":"10.3233\/JPD-191702","article-title":"Gastrointestinal immunity and alpha-synuclein","volume":"9","author":"Barbut","year":"2019","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.tem.2021.11.005_bb0155","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1016\/j.bpj.2010.07.056","article-title":"Effects of curvature and composition on \u03b1-synuclein binding to lipid vesicles","volume":"99","author":"Middleton","year":"2010","journal-title":"Biophys. J."},{"key":"10.1016\/j.tem.2021.11.005_bb0160","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1159\/000477990","article-title":"A role for neuronal alpha-synuclein in gastrointestinal immunity","volume":"9","author":"Stolzenberg","year":"2017","journal-title":"J. Innate Immun."},{"key":"10.1016\/j.tem.2021.11.005_bb0165","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.92295","article-title":"\u03b1-Synuclein in gut endocrine cells and its implications for Parkinson\u2019s disease","volume":"2","author":"Chandra","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.tem.2021.11.005_bb0170","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.neuron.2019.05.035","article-title":"Transneuronal propagation of pathologic \u03b1-synuclein from the gut to the brain models Parkinson\u2019s disease","volume":"103","author":"Kim","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.tem.2021.11.005_bb0175","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.nbd.2018.01.008","article-title":"Induction of alpha-synuclein pathology in the enteric nervous system of the rat and non-human primate results in gastrointestinal dysmotility and transient CNS pathology","volume":"112","author":"Manfredsson","year":"2018","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.tem.2021.11.005_bb0180","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/ana.24448","article-title":"Vagotomy and subsequent risk of Parkinson's disease","volume":"78","author":"Svensson","year":"2015","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.tem.2021.11.005_bb0185","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00401-019-02040-w","article-title":"Evidence for bidirectional and trans-synaptic parasympathetic and sympathetic propagation of alpha-synuclein in rats","volume":"138","author":"Van Den Berge","year":"2019","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.tem.2021.11.005_bb0190","doi-asserted-by":"crossref","first-page":"S281","DOI":"10.3233\/JPD-191721","article-title":"Brain-first versus gut-first Parkinson's disease: a hypothesis","volume":"9","author":"Borghammer","year":"2019","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.tem.2021.11.005_bb0195","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1002\/mds.26605","article-title":"Neuropathological basis of nonmotor manifestations of Parkinson's disease","volume":"31","author":"Adler","year":"2016","journal-title":"Mov. Disord."},{"key":"10.1016\/j.tem.2021.11.005_bb0200","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1002\/mds.22775","article-title":"Incidental Lewy body disease restricted to the heart and stellate ganglia","volume":"24","author":"Miki","year":"2009","journal-title":"Mov. Disord."},{"key":"10.1016\/j.tem.2021.11.005_bb0205","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/nen.0b013e3180517454","article-title":"Analysis of the adrenal gland is useful for evaluating pathology of the peripheral autonomic nervous system in Lewy body disease","volume":"66","author":"Fumimura","year":"2007","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.tem.2021.11.005_bb0210","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/ana.24648","article-title":"Pathological \u03b1-synuclein in gastrointestinal tissues from prodromal Parkinson disease patients","volume":"79","author":"Stokholm","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.tem.2021.11.005_bb0215","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/mds.26473","article-title":"Alpha-synuclein in gastric and colonic mucosa in Parkinson's disease: limited role as a biomarker","volume":"31","author":"Chung","year":"2016","journal-title":"Mov. Disord."},{"key":"10.1016\/j.tem.2021.11.005_bb0220","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3389\/fnins.2015.00059","article-title":"Features of alpha-synuclein that could explain the progression and irreversibility of Parkinson's disease","volume":"9","author":"Gallegos","year":"2015","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.tem.2021.11.005_bb0225","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/ncb748","article-title":"alpha-Synuclein is phosphorylated in synucleinopathy lesions","volume":"4","author":"Fujiwara","year":"2002","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.tem.2021.11.005_bb0230","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3233\/JPD-160779","article-title":"Implication of alpha-synuclein phosphorylation at S129 in synucleinopathies: what have we learned in the last decade?","volume":"6","author":"Oueslati","year":"2016","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.tem.2021.11.005_bb0235","article-title":"Detection of phosphorylated alpha-synuclein in the muscularis propria of the gastrointestinal tract is a sensitive predictor for Parkinson's disease","volume":"2020","author":"Beck","year":"2020","journal-title":"Parkinsons Dis."},{"key":"10.1016\/j.tem.2021.11.005_bb0240","doi-asserted-by":"crossref","first-page":"18914","DOI":"10.1074\/jbc.RA118.005603","article-title":"Physiological C-terminal truncation of \u03b1-synuclein potentiates the prion-like formation of pathological inclusions","volume":"293","author":"Sorrentino","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tem.2021.11.005_bb0245","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s41422-019-0241-9","article-title":"Initiation of Parkinson's disease from gut to brain by \u03b4-secretase","volume":"30","author":"Ahn","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.tem.2021.11.005_bb0250","first-page":"2","article-title":"Targeting neurons in the gastrointestinal tract to treat Parkinson's disease","volume":"1","author":"Hauser","year":"2019","journal-title":"Clin. Park. Relat. Disord."},{"key":"10.1016\/j.tem.2021.11.005_bb0255","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1021\/ar050073t","article-title":"The aggregation and fibrillation of alpha-synuclein","volume":"39","author":"Fink","year":"2006","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.tem.2021.11.005_bb0260","doi-asserted-by":"crossref","first-page":"E1009","DOI":"10.1073\/pnas.1610586114","article-title":"A natural product inhibits the initiation of \u03b1-synuclein aggregation and suppresses its toxicity","volume":"114","author":"Perni","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tem.2021.11.005_bb0265","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.nbd.2012.09.007","article-title":"Colonic inflammation in Parkinson's disease","volume":"50","author":"Devos","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.tem.2021.11.005_bb0270","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.4103\/1673-5374.270308","article-title":"Leaky gut, dysbiosis, and enteric glia activation: the trilogy behind the intestinal origin of Parkinson's disease","volume":"15","author":"Seguella","year":"2020","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.tem.2021.11.005_bb0275","doi-asserted-by":"crossref","first-page":"67","DOI":"10.14802\/jmd.18067","article-title":"Altered gut microbiome and intestinal pathology in Parkinson's disease","volume":"12","author":"Chiang","year":"2019","journal-title":"J. Mov. Disord."},{"key":"10.1016\/j.tem.2021.11.005_bb0280","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/mds.27581","article-title":"Unraveling gut microbiota in Parkinson's disease and atypical parkinsonism","volume":"34","author":"Barichella","year":"2019","journal-title":"Mov. Disord."},{"key":"10.1016\/j.tem.2021.11.005_bb0285","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1002\/ana.26128","article-title":"Gut microbiome signatures of risk and prodromal markers of Parkinson disease","volume":"90","author":"Heinzel","year":"2021","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.tem.2021.11.005_bb0290","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41531-021-00156-z","article-title":"Meta-analysis of the Parkinson's disease gut microbiome suggests alterations linked to intestinal inflammation","volume":"7","author":"Romano","year":"2021","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.tem.2021.11.005_bb0295","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41531-020-0112-6","article-title":"Characterizing dysbiosis of gut microbiome in PD: evidence for overabundance of opportunistic pathogens","volume":"6","author":"Wallen","year":"2020","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.tem.2021.11.005_bb0300","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1126\/science.aad3369","article-title":"Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity","volume":"352","author":"Zhernakova","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.tem.2021.11.005_bb0305","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2165\/00003088-200241040-00003","article-title":"Clinical pharmacokinetic and pharmacodynamic properties of drugs used in the treatment of Parkinson's disease","volume":"41","author":"Deleu","year":"2002","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.tem.2021.11.005_bb0310","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/01.wnf.0000166393.33781.87","article-title":"Entacapone increases levodopa exposure and reduces plasma levodopa variability when used with Sinemet CR","volume":"28","author":"Paija","year":"2005","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.tem.2021.11.005_bb0315","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/s41467-019-08294-y","article-title":"Gut bacterial tyrosine decarboxylases restrict levels of levodopa in the treatment of Parkinson's disease","volume":"10","author":"van Kessel","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tem.2021.11.005_bb0320","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/mds.26942","article-title":"Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome","volume":"32","author":"Hill-Burns","year":"2017","journal-title":"Mov. Disord."},{"key":"10.1016\/j.tem.2021.11.005_bb0325","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.574529","article-title":"Effect of Levodopa initiation on the gut microbiota in Parkinson's disease","volume":"12","author":"Palacios","year":"2021","journal-title":"Front. Neurol."},{"key":"10.1016\/j.tem.2021.11.005_bb0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2020.109564","article-title":"Dysbiosis in Parkinson's disease might be triggered by certain antibiotics","volume":"137","author":"Tern\u00e1k","year":"2020","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.tem.2021.11.005_bb0335","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12454","article-title":"Review: impact of Helicobacter pylori on Alzheimer's disease: what do we know so far?","volume":"23","author":"Doulberis","year":"2018","journal-title":"Helicobacter"},{"key":"10.1016\/j.tem.2021.11.005_bb0340","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3988\/jcn.2016.12.2.147","article-title":"Association between Parkinson's disease and Helicobacter pylori","volume":"12","author":"\u00c7amc\u0131","year":"2016","journal-title":"J. Clin. Neurol."},{"key":"10.1016\/j.tem.2021.11.005_bb0345","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1002\/mds.22190","article-title":"Helicobacter pylori infection and motor fluctuations in patients with Parkinson's disease","volume":"23","author":"Lee","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.tem.2021.11.005_bb0350","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0251042","article-title":"Helicobacter pylori eradication improves motor fluctuations in advanced Parkinson\u2019s disease patients: a prospective cohort study (HP-PD trial)","volume":"16","author":"Lolekha","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.tem.2021.11.005_bb0355","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13099-021-00420-w","article-title":"Association of small intestinal bacterial overgrowth with Parkinson's disease: a systematic review and meta-analysis","volume":"13","author":"Li","year":"2021","journal-title":"Gut Pathog."},{"key":"10.1016\/j.tem.2021.11.005_bb0360","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.parkreldis.2014.02.019","article-title":"Small intestinal bacterial overgrowth in Parkinson's disease","volume":"20","author":"Tan","year":"2014","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.tem.2021.11.005_bb0365","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/s41575-019-0157-3","article-title":"The role of short-chain fatty acids in microbiota-gut-brain communication","volume":"16","author":"Dalile","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.tem.2021.11.005_bb0370","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13024-021-00427-6","article-title":"Relationships of gut microbiota, short-chain fatty acids, inflammation, and the gut barrier in Parkinson's disease","volume":"16","author":"Aho","year":"2021","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.tem.2021.11.005_bb0375","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.neuint.2016.06.011","article-title":"The neuropharmacology of butyrate: the bread and butter of the microbiota-gut-brain axis?","volume":"99","author":"Stilling","year":"2016","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.tem.2021.11.005_bb0380","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.cell.2016.11.018","article-title":"Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease","volume":"167","author":"Sampson","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.tem.2021.11.005_bb0385","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1002\/mds.28016","article-title":"Plasma short-chain fatty acids in patients with Parkinson's disease","volume":"35","author":"Shin","year":"2020","journal-title":"Mov. Disord."},{"key":"10.1016\/j.tem.2021.11.005_bb0390","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/glia.20467","article-title":"Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration","volume":"55","author":"Qin","year":"2007","journal-title":"Glia"},{"key":"10.1016\/j.tem.2021.11.005_bb0395","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1002\/mds.26307","article-title":"Colonic bacterial composition in Parkinson's disease","volume":"30","author":"Keshavarzian","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.tem.2021.11.005_bb0400","doi-asserted-by":"crossref","first-page":"30891","DOI":"10.1038\/srep30891","article-title":"Exposure to bacterial endotoxin generates a distinct strain of \u03b1-synuclein fibril","volume":"6","author":"Kim","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tem.2021.11.005_bb0405","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41531-021-00218-2","article-title":"Exploring human-genome gut-microbiome interaction in Parkinson's disease","volume":"7","author":"Wallen","year":"2021","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.tem.2021.11.005_bb0410","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2020.570658","article-title":"Gut microbiota approach-a new strategy to treat Parkinson's disease","volume":"10","author":"Liu","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.tem.2021.11.005_bb0415","first-page":"13","article-title":"Specific immune modulation of experimental colitis drives enteric alpha-synuclein accumulation and triggers age-related Parkinson-like brain pathology","volume":"2","author":"Grathwohl","year":"2021","journal-title":"Free Neuropathol."},{"key":"10.1016\/j.tem.2021.11.005_bb0420","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3389\/fcimb.2020.00151","article-title":"Current sampling methods for gut microbiota: a call for more precise devices","volume":"10","author":"Tang","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.tem.2021.11.005_bb0425","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2020.602697","article-title":"Caffeine and Parkinson\u2019s disease: multiple benefits and emerging mechanisms","volume":"14","author":"Ren","year":"2020","journal-title":"Front. Neurosci."}],"updated-by":[{"DOI":"10.1016\/j.tem.2022.01.003","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000}}],"container-title":["Trends in Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104327602100268X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104327602100268X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T20:42:01Z","timestamp":1760906521000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104327602100268X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":85,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S104327602100268X"],"URL":"https:\/\/doi.org\/10.1016\/j.tem.2021.11.005","relation":{},"ISSN":["1043-2760"],"issn-type":[{"value":"1043-2760","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Digesting recent findings: gut alpha-synuclein, microbiome changes in Parkinson\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Trends in Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tem.2021.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}